CLINICAL-PHARMACOLOGY OF PRAZOSIN IN HYPERTENSIVE PATIENTS WITH CHRONIC-RENAL-FAILURE

被引：13

作者：

CHAIGNON, M

LEROUX, E

AUBERT, P

LUCSKO, M

SAFAR, M

FLOUVAT, B

GUEDON, J

机构：

[1] HOP AMBROISE PARE,TOXICOL LAB,F-92100 BOULOGNE,FRANCE

[2] HOP BROUSSAIS,CTR RECH HYPERTENS ARTERIELLE,F-75674 PARIS 14,FRANCE

[3] CTR MED CHIRURG FOCH,INSERM,UNITE RECH 27,F-92151 SURESNES,FRANCE

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1981年 / 3卷 / 01期

关键词：

D O I：

10.1097/00005344-198101000-00013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：151 / 160

页数：10

共 23 条

[1]

BAILEY RR, 1976, NEW ZEAL MED J, V84, P467

[2] PRAZOSIN, PHARMACOKINETICS AND CONCENTRATION EFFECT [J].

BATEMAN, DN ;

HOBBS, DC ;

TWOMEY, TM ;

STEVENS, EA ;

RAWLINS, MD .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :177-181

[3]

BIANCHETTI G, 1976, Clinical Pharmacokinetics, V1, P373, DOI 10.2165/00003088-197601050-00004

[4]

CHAU NP, CLIN PHARMACOL THER

[5]

CHEN WT, 1978, T AM SOC ART INT ORG, V24, P682

[6]

COLLINS IS, 1974, DEC ANN M AUSTR SOC

[7] USE OF PRAZOSIN IN MANAGEMENT OF HYPERTENSION IN PATIENTS WITH CHRONIC RENAL-FAILURE AND IN RENAL-TRANSPLANT RECIPIENTS [J].

CURTIS, JR ;

BATEMAN, FJA .

BRITISH MEDICAL JOURNAL, 1975, 4 (5994) :432-434

[8]

FABRE J, 1979, NOUV PRESSE MED, V8, P2677

[9]

FLOUVAT B, 1979, THERAPIE, V34, P63

[10]

FLOUVAT B, 1978, P EUROPEAN PRAZOSIN, P28

← 1 2 3 →